Company Name

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Vestibulum porta libero erat. Nullam at ipsum quis felis egestas vulputate nec nec ligula.

FDA approves stomach-draining obesity treatment

This rendering provided by Aspire Bariatrics, Inc. demonstrates the use of the AspireAssist weight loss device, approved by the Food and Drug Administration on Tuesday, June 14, 2016. The AspireAssist system consists of a thin tube implanted in the stomach, connecting to an outside port on the skin of the belly, which itself is connected to an external device, which helps remove nearly a third of the food stored in the stomach before calories are absorbed into the body, causing weight loss. (Aspire Bariatrics, Inc. via AP) MANDATORY CREDITWASHINGTON (AP) — A new weight loss device offers a novel approach to cutting calories: draining them from the stomach before they are fully digested.